TrialBMC cancer2014

Randomized phase II study of pemetrexed/cisplatin with or without axitinib for non-squamous non-small-cell lung cancer.

Chandra P Belani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.